The Role of Beta-Hydroxybutyrate in Reducing Inflammation and Metabolic Issues from Uric Acid
Author Information
Author(s): Remund Nicole P., Larsen John G., Shin Marley J., Warren Cali E., Palmer Isabelle L., Kim Iris J., Cooper-Leavitt Elijah T., Clarke Derek M., Beus Colson G., Johnson Richard J., Arroyo Juan A., Reynolds Paul R., Bikman Benjamin T.
Primary Institution: Department of Cell Biology and Physiology, Brigham Young University, Provo, UT, USA
Hypothesis
This study explores the role of beta-hydroxybutyrate (BHB) in mitigating the inflammatory and metabolic effects of elevated uric acid levels.
Conclusion
BHB has therapeutic potential by counteracting the inflammatory and metabolic disruptions caused by elevated uric acid.
Supporting Evidence
- BHB co-treatment improved cell survival and reduced cytokine levels in muscle cells treated with uric acid.
- Uric acid treatment increased pro-inflammatory cytokines, which were suppressed by BHB.
- BHB restored insulin sensitivity impaired by uric acid.
Takeaway
When uric acid levels are high, it can cause inflammation and make it hard for the body to use insulin. This study found that a substance called BHB can help reduce these problems.
Methodology
Murine muscle cells were treated with uric acid and beta-hydroxybutyrate to assess inflammatory responses and cell viability.
Limitations
The study was conducted in a cell culture model, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website